Clinical trials
Recruiting Reperfusion Injury trials in China
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
6 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2023 | 1 |
| 2025 | 3 |
| 2026 | 2 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 6 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| The Second Hospital of Anhui Medical University | 2 |
| First Affiliated Hospital Xi'an Jiaotong University | 1 |
| Fujian Medical University | 1 |
| Hubei Cancer Hospital | 1 |
| Jinling Hospital, China | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Reperfusion Injury | 6 |
| Acute Kidney Injury | 1 |
| Breast Neoplasms | 1 |
| Inflammation | 1 |
| Kidney Neoplasms | 1 |
| Postoperative Complications | 1 |
Trials
Showing 1 to 6 of 6. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.